Cargando…

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features

BACKGROUND: There is increasing incidence of pulmonary nodules due to the promotion and popularization of low-dose computed tomography (LDCT) screening for potential populations with suspected lung cancer. However, a high rate of false-positive and concern of radiation-related cancer risk of repeate...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Leidi, Chang, Ning, Yang, Tingyi, Lang, Yuxiang, Zhang, Yong, Che, Yinggang, Xi, Hangtian, Zhang, Weiqi, Song, Qingtao, Zhou, Ying, Yang, Xuemin, Yang, Juanli, Qu, Shuoyao, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069812/
https://www.ncbi.nlm.nih.gov/pubmed/35530343
http://dx.doi.org/10.3389/fonc.2022.883543
_version_ 1784700510559797248
author Xu, Leidi
Chang, Ning
Yang, Tingyi
Lang, Yuxiang
Zhang, Yong
Che, Yinggang
Xi, Hangtian
Zhang, Weiqi
Song, Qingtao
Zhou, Ying
Yang, Xuemin
Yang, Juanli
Qu, Shuoyao
Zhang, Jian
author_facet Xu, Leidi
Chang, Ning
Yang, Tingyi
Lang, Yuxiang
Zhang, Yong
Che, Yinggang
Xi, Hangtian
Zhang, Weiqi
Song, Qingtao
Zhou, Ying
Yang, Xuemin
Yang, Juanli
Qu, Shuoyao
Zhang, Jian
author_sort Xu, Leidi
collection PubMed
description BACKGROUND: There is increasing incidence of pulmonary nodules due to the promotion and popularization of low-dose computed tomography (LDCT) screening for potential populations with suspected lung cancer. However, a high rate of false-positive and concern of radiation-related cancer risk of repeated CT scanning remains a major obstacle to its wide application. Here, we aimed to investigate the clinical value of a non-invasive and simple test, named the seven autoantibodies (7-AABs) assay (P53, PGP9.5, SOX2, GAGE7, GUB4-5, MAGEA1, and CAGE), in distinguishing malignant pulmonary diseases from benign ones in routine clinical practice, and construct a neural network diagnostic model with the development of machine learning methods. METHOD: A total of 933 patients with lung diseases and 744 with lung nodules were identified. The serum levels of the 7-AABs were tested by an enzyme-linked Immunosorbent assay (ELISA). The primary goal was to assess the sensitivity and specificity of the 7-AABs panel in the detection of lung cancer. ROC curves were used to estimate the diagnosis potential of the 7-AABs in different groups. Next, we constructed a machine learning model based on the 7-AABs and imaging features to evaluate the diagnostic efficacy in lung nodules. RESULTS: The serum levels of all 7-AABs in the malignant lung diseases group were significantly higher than that in the benign group. The sensitivity and specificity of the 7-AABs panel test were 60.7% and 81.5% in the whole group, and 59.7% and 81.1% in cases with early lung nodules. Comparing to the 7-AABs panel test alone, the neural network model improved the AUC from 0.748 to 0.96 in patients with pulmonary nodules. CONCLUSION: The 7-AABs panel may be a promising method for early detection of lung cancer, and we constructed a new diagnostic model with better efficiency to distinguish malignant lung nodules from benign nodules which could be used in clinical practice.
format Online
Article
Text
id pubmed-9069812
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90698122022-05-05 Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features Xu, Leidi Chang, Ning Yang, Tingyi Lang, Yuxiang Zhang, Yong Che, Yinggang Xi, Hangtian Zhang, Weiqi Song, Qingtao Zhou, Ying Yang, Xuemin Yang, Juanli Qu, Shuoyao Zhang, Jian Front Oncol Oncology BACKGROUND: There is increasing incidence of pulmonary nodules due to the promotion and popularization of low-dose computed tomography (LDCT) screening for potential populations with suspected lung cancer. However, a high rate of false-positive and concern of radiation-related cancer risk of repeated CT scanning remains a major obstacle to its wide application. Here, we aimed to investigate the clinical value of a non-invasive and simple test, named the seven autoantibodies (7-AABs) assay (P53, PGP9.5, SOX2, GAGE7, GUB4-5, MAGEA1, and CAGE), in distinguishing malignant pulmonary diseases from benign ones in routine clinical practice, and construct a neural network diagnostic model with the development of machine learning methods. METHOD: A total of 933 patients with lung diseases and 744 with lung nodules were identified. The serum levels of the 7-AABs were tested by an enzyme-linked Immunosorbent assay (ELISA). The primary goal was to assess the sensitivity and specificity of the 7-AABs panel in the detection of lung cancer. ROC curves were used to estimate the diagnosis potential of the 7-AABs in different groups. Next, we constructed a machine learning model based on the 7-AABs and imaging features to evaluate the diagnostic efficacy in lung nodules. RESULTS: The serum levels of all 7-AABs in the malignant lung diseases group were significantly higher than that in the benign group. The sensitivity and specificity of the 7-AABs panel test were 60.7% and 81.5% in the whole group, and 59.7% and 81.1% in cases with early lung nodules. Comparing to the 7-AABs panel test alone, the neural network model improved the AUC from 0.748 to 0.96 in patients with pulmonary nodules. CONCLUSION: The 7-AABs panel may be a promising method for early detection of lung cancer, and we constructed a new diagnostic model with better efficiency to distinguish malignant lung nodules from benign nodules which could be used in clinical practice. Frontiers Media S.A. 2022-04-21 /pmc/articles/PMC9069812/ /pubmed/35530343 http://dx.doi.org/10.3389/fonc.2022.883543 Text en Copyright © 2022 Xu, Chang, Yang, Lang, Zhang, Che, Xi, Zhang, Song, Zhou, Yang, Yang, Qu and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Xu, Leidi
Chang, Ning
Yang, Tingyi
Lang, Yuxiang
Zhang, Yong
Che, Yinggang
Xi, Hangtian
Zhang, Weiqi
Song, Qingtao
Zhou, Ying
Yang, Xuemin
Yang, Juanli
Qu, Shuoyao
Zhang, Jian
Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
title Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
title_full Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
title_fullStr Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
title_full_unstemmed Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
title_short Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
title_sort development of diagnosis model for early lung nodules based on a seven autoantibodies panel and imaging features
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069812/
https://www.ncbi.nlm.nih.gov/pubmed/35530343
http://dx.doi.org/10.3389/fonc.2022.883543
work_keys_str_mv AT xuleidi developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT changning developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT yangtingyi developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT langyuxiang developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT zhangyong developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT cheyinggang developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT xihangtian developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT zhangweiqi developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT songqingtao developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT zhouying developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT yangxuemin developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT yangjuanli developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT qushuoyao developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures
AT zhangjian developmentofdiagnosismodelforearlylungnodulesbasedonasevenautoantibodiespanelandimagingfeatures